Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, announced it has acquired Impact Research Institute (Waco, TX) and the clinical trials unit of Liver Institute Northwest (Seattle, WA), aggressively expanding its capabilities in liver disease research, including MASH (metabolic dysfunction-associated steatohepatitis) and MASLD (metabolic dysfunction-associated steatotic liver disease)Velocity is a major player in this space with 23 sites capable of performing MASH/MASLD studies globally. With the two recent site acquisitions, Velocity adds two internationally renowned researchers and key opinion leaders (KOL) in liver disease research as principal investigators.
Read the full article: Velocity Aggressively Expands MASH/MASLD Capabilities with Latest Site Acquisitions //
Source: https://www.globenewswire.com/news-release/2023/10/25/2766368/0/en/Velocity-aggressively-expands-MASH-MASLD-capabilities-with-latest-site-acquisitions.html